One reason why BCR-ABL-induced CML-like disorders are more susceptible to Bisindolylmaleimide IX is that this agent causes increased cells cycle arrest due to increased DNA damage. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.